DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q1 2025 Earnings Call Transcript
Operator: Good morning ladies and gentlemen, and welcome to the DiaMedica Therapeutics First Quarter 2025 Conference Call.
Diamedica Therapeutics Inc. (DMAC)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Omega Advisors Leon Cooperman | 1,625,000 | $6,158,750 | 0.24% | |
| 2. | Millennium Management Israel Englander | 336,880 | $1,276,775 | +298% | 0% |
| 3. | Citadel Investment Group Ken Griffin | 53,700 | $203,523 | +234% | 0% |
| 4. | Jain Global LLC Bobby Jain | 27,679 | $104,903 | 0% | |
| 5. | Leucadia National Ian Cumming And Joseph Steinberg | 26,000 | $98,540 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.50 | 1,200,000 | Large Shareholder | 5,526,435 | 2024-06-28 | Filing | |
| $2.50 | 1,200,000 | Large Shareholder | 5,221,608 | 2024-06-28 | Filing | |
| $2.46 | 20,000 | Officer | 527,114 | 2023-11-16 | Filing | |
| $3.40 | 1,470,588 | Large Shareholder | 4,326,435 | 2023-06-23 | Filing | |
| $3.91 | 65,000 | Director | 360,355 | 2023-06-23 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.24 | 2,855,847 | Large Shareholder | 0 | 2022-12-02 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,351,467 | $5,122,060 | 0% | |
| 2. | 606,435 | $2,298,389 | 0.01% | |
| 3. | 600,000 | $2,274,000 | 5.33% | |
| 4. | 556,593 | $2,109,487 | 0% | |
| 5. | 382,317 | $1,448,981 | 0.39% |
News See All
DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q4 2024 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the DiaMedica Therapeutics Full Year 2024 Conference Call.
DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q3 2024 Earnings Call Transcript
Operator: Good morning ladies and gentlemen and welcome to the DiaMedica Therapeutics Third Quarter 2024 Conference Call.
DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q2 2024 Earnings Call Transcript
Operator: Good morning ladies and gentlemen and welcome to the DiaMedica Therapeutics Second Quarter 2024 Conference Call.
DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q1 2024 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the DiaMedica Therapeutics First Quarter 2024 Conference Call.
DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q4 2023 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the DiaMedica Therapeutics Full Year 2023 Conference Call.
Billionaire Lee Cooperman's 10 Stock Picks with Huge Upside Potential
In this article, we discuss billionaire Lee Cooperman's 10 stock picks with huge upside potential. To skip the details of Mr.
DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q3 2023 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the DiaMedica Therapeutics Third Quarter 2023 Conference Call.
DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q2 2023 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the DiaMedica Therapeutics Second Quarter 2023 Conference Call.
Hedge Fund and Insider Trading News: Crispin Odey, Starboard Value, Tiger Management, DiaMedica Therapeutics Inc (DMAC), Asana, Inc. (ASAN), and More
Crispin Odey, on paper, is a billionaire — commanding a vast wealth built over decades that’s unlikely to unravel as fast as his tenure atop Odey Asset Management.
Billionaire Hedge Funds
